Understanding why CLL patients stop responding to treatment, and options for salvage therapies
Why do charities need to keep funding research into leukemia and blood cancer in general?
Updates from the CLL14 and CLL2-GiVe trials on CLL
Drug combinations in CLL: ibrutinib, idelalisib and more
How to treat a previously treated CLL patient